Eton Pharmaceuticals, Inc.

Ownership Transactions Reported by 9 Insiders

Symbol: ETON on Nasdaq
Industry: Pharmaceutical Preparations
Location: 21925 W. Field Parkway, Suite 235, Deer Park, IL

Insiders trading volume in the past year

	Insiders	Shares	%	Avg Price	Total $
Buys	1	+118K	100%	$4.98	+$585K
Sells	0
Net	+1	+118K	100%		+$585K

Eton Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Opaleye Management Inc.	10%+ Owner	$22.1M	+$585K	+2.72%	Oct 23, 2024
David Krempa	Chief Business Officer	$4.09M			Oct 2, 2024
Norbert Riedel	Director				Feb 13, 2024
Wilson Troutman	CFO and Secretary				Feb 7, 2022
Sean Brynjelsen	President & CEO, Director				Feb 13, 2024
Charles J. Casamento	Director				Feb 13, 2024
Paul V. Maier	Director				Feb 13, 2024
Jennifer McKie Adams	Director				Feb 13, 2024
James R. Gruber	Chief Financial Officer				Feb 13, 2024

Recent Insider Transactions by Companies or Individuals for Eton Pharmaceuticals, Inc.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.